Use Case

New Precision Oncology Approach for Rare Cancer Patients

A new study demonstrates the feasibility and clinical value of whole-genome/exome sequencing and RNA sequencing in patients suffering from early onset or rare cancer types. 

Learn more

Subscribe here!

To stay up to date with the developments around GHGA, news and events please sign up for our newsletter.